Is a
Patent attributes
Current Assignee
Patent Jurisdiction
Patent Number
Date of Patent
July 3, 2007
Patent Application Number
11091882
Date Filed
March 28, 2005
Patent Primary Examiner
Patent abstract
The present invention discloses the use of a mutant Leishmania as a suicidal vaccine wherein the mutant Leishmania is responsive to external signals to become porphyric and commit suicidal cytolysis. The mutant can be selected from natural Leishmania species or constructed by genetic engineering.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
